Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Jan;99(1):129–136. doi: 10.1111/j.1365-2249.1995.tb03483.x

IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils.

L A Bober 1, T A Waters 1, C C Pugliese-Sivo 1, L M Sullivan 1, S K Narula 1, M J Grace 1
PMCID: PMC1534134  PMID: 7529148

Abstract

IL-4 is a T-helper cell derived cytokine that has effects on myelomonocytic cell maturation and activation. We have studied the effect of IL-4 on neutrophilic maturation using the cell line HL-60 and found that it has a profound effect on the maturation and activation of the cell line. The treatment of HL-60 cells with recombinant hu IL-4 (0.15 to 15.0 ng/ml) induced a shift in the percentage of HL-60 cells staining positive for chloroacetate esterase enzyme activity (indicating commitment to the neutrophilic lineage). IL-4 increased surface expression of the neutrophil-lineage antigen WEM G11, the complement receptors CR3 (CD11b) and CR1 (CD35), but not for the monocyte differentiation antigen CD14. IL-4 treated HL-60 cells demonstrated enhanced Fc- and complement-mediated phagocytic capacity and increased hexose-monophosphate shunt activity. In addition, IL-4 was capable of sustaining the neutrophil maturation of HL-60 cells that had been pre-treated for 24 h with DMSO. To investigate the effect of IL-4 on the mature neutrophil, we studied freshly isolated and rested human peripheral blood neutrophils. In the absence of other stimuli, neutrophils were induced by IL-4 to have significantly elevated phagocytic responses. The response was specific since treatment with anti-human IL-4 abolished phagocytic stimulation. Finally, IL-4 treatment also stimulated resting neutrophils to migrate toward zymosan-activated serum (ZAS) and human IL-5. The results demonstrate that IL-4 is a potent maturation factor for myelocytes to become neutrophils and that IL-4 can stimulate resting mature neutrophils.

Full text

PDF
129

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baehner R. L., Nathan D. G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med. 1968 May 2;278(18):971–976. doi: 10.1056/NEJM196805022781801. [DOI] [PubMed] [Google Scholar]
  2. Boey H., Rosenbaum R., Castracane J., Borish L. Interleukin-4 is a neutrophil activator. J Allergy Clin Immunol. 1989 May;83(5):978–984. doi: 10.1016/0091-6749(89)90115-2. [DOI] [PubMed] [Google Scholar]
  3. Broxmeyer H. E., Lu L., Cooper S., Tushinski R., Mochizuki D., Rubin B. Y., Gillis S., Williams D. E. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. J Immunol. 1988 Dec 1;141(11):3852–3862. [PubMed] [Google Scholar]
  4. Campbell P. A. The neutrophil, a professional killer of bacteria, may be controlled by T cells. Clin Exp Immunol. 1990 Feb;79(2):141–143. doi: 10.1111/j.1365-2249.1990.tb05169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crawford R. M., Finbloom D. S., Ohara J., Paul W. E., Meltzer M. S. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens. J Immunol. 1987 Jul 1;139(1):135–141. [PubMed] [Google Scholar]
  6. Defrance T., Aubry J. P., Rousset F., Vanbervliet B., Bonnefoy J. Y., Arai N., Takebe Y., Yokota T., Lee F., Arai K. Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes. J Exp Med. 1987 Jun 1;165(6):1459–1467. doi: 10.1084/jem.165.6.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Geiger T., Arnold J., Rordorf C., Henn R., Vosbeck K. Interferon-gamma overcomes the glucocorticoid-mediated and the interleukin-4-mediated inhibition of interleukin-1 beta synthesis in human monocytes. Lymphokine Cytokine Res. 1993 Oct;12(5):271–278. [PubMed] [Google Scholar]
  8. Hogg J. C., James A. L., Pare P. D. Evidence for inflammation in asthma. Am Rev Respir Dis. 1991 Mar;143(3 Pt 2):S39–S42. doi: 10.1164/ajrccm/143.3_Pt_2.S39. [DOI] [PubMed] [Google Scholar]
  9. Kapp A., Zeck-Kapp G. Interleukin-5-induced granulocyte activation in atopic patients. Br J Dermatol. 1991 Aug;125(2):108–115. doi: 10.1111/j.1365-2133.1991.tb06056.x. [DOI] [PubMed] [Google Scholar]
  10. Kishi K., Ihle J. N., Urdal D. L., Ogawa M. Murine B-cell stimulatory factor-1 (BSF-1)/interleukin-4 (IL-4) is a multilineage colony-stimulating factor that acts directly on primitive hemopoietic progenitors. J Cell Physiol. 1989 Jun;139(3):463–468. doi: 10.1002/jcp.1041390303. [DOI] [PubMed] [Google Scholar]
  11. Kroegel C. The role of eosinophils in asthma. Lung. 1990;168 (Suppl):5–17. doi: 10.1007/BF02718107. [DOI] [PubMed] [Google Scholar]
  12. Larsen G. L., Bethel R. A., Irvin C. G., Martin R. J., Uchida D. A. Granulocytes and airway reactivity. Am Rev Respir Dis. 1991 Mar;143(3 Pt 2):S64–S65. doi: 10.1164/ajrccm/143.3_Pt_2.S64. [DOI] [PubMed] [Google Scholar]
  13. Lauener R. P., Goyert S. M., Geha R. S., Vercelli D. Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur J Immunol. 1990 Nov;20(11):2375–2381. doi: 10.1002/eji.1830201103. [DOI] [PubMed] [Google Scholar]
  14. Lopez A. F., Sanderson C. J., Gamble J. R., Campbell H. D., Young I. G., Vadas M. A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med. 1988 Jan 1;167(1):219–224. doi: 10.1084/jem.167.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lord J. M., Bunce C. M., Duncan R. J., Phillips I. D., Shennan K. I., Docherty K., Brown G. Changes in insulin receptor expression in HL60 cells induced to differentiate towards neutrophils or monocytes. J Mol Endocrinol. 1988 Nov;1(3):197–201. doi: 10.1677/jme.0.0010197. [DOI] [PubMed] [Google Scholar]
  16. Morley J., Smith D. Lung inflammation, its significance for asthma therapy. Agents Actions. 1989 Jan;26(1-2):31–39. doi: 10.1007/BF02126555. [DOI] [PubMed] [Google Scholar]
  17. Mosmann T. R., Bond M. W., Coffman R. L., Ohara J., Paul W. E. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5654–5658. doi: 10.1073/pnas.83.15.5654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Möller A., Grabbe J., Czarnetzki B. M. Mast cells and their mediators in immediate and delayed immune reactions. Skin Pharmacol. 1991;4 (Suppl 1):56–63. doi: 10.1159/000210983. [DOI] [PubMed] [Google Scholar]
  19. Noma T., Nakakubo H., Hama K., Honjo T. Multiple effects of human recombinant interleukin 4 on human myeloid monocyte cell lines. Immunol Lett. 1989 Jun 15;21(4):323–328. doi: 10.1016/0165-2478(89)90027-8. [DOI] [PubMed] [Google Scholar]
  20. Park L. S., Friend D., Sassenfeld H. M., Urdal D. L. Characterization of the human B cell stimulatory factor 1 receptor. J Exp Med. 1987 Aug 1;166(2):476–488. doi: 10.1084/jem.166.2.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Patterson-Delafield J., Lehrer R. I. A simple microscopic method for identifying and quantitating phagocytic cells in vitro. J Immunol Methods. 1977;18(3-4):377–379. doi: 10.1016/0022-1759(77)90191-0. [DOI] [PubMed] [Google Scholar]
  22. Shapira S. K., Vercelli D., Jabara H. H., Fu S. M., Geha R. S. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J Exp Med. 1992 Jan 1;175(1):289–292. doi: 10.1084/jem.175.1.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sonoda Y., Okuda T., Yokota S., Maekawa T., Shizumi Y., Nishigaki H., Misawa S., Fujii H., Abe T. Actions of human interleukin-4/B-cell stimulatory factor-1 on proliferation and differentiation of enriched hematopoietic progenitor cells in culture. Blood. 1990 Apr 15;75(8):1615–1621. [PubMed] [Google Scholar]
  24. Sullivan L. M., Bober L. A., Grace M. J., Braun S., Macosko H. D., Payvandi F., Pugliese-Sivo C. C., Narula S. K. Potential interaction of interleukin-4 with endogenous cytokines in vivo. Pathobiology. 1994;62(2):59–72. doi: 10.1159/000163880. [DOI] [PubMed] [Google Scholar]
  25. Swain S. L., Bradley L. M., Croft M., Tonkonogy S., Atkins G., Weinberg A. D., Duncan D. D., Hedrick S. M., Dutton R. W., Huston G. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev. 1991 Oct;123:115–144. doi: 10.1111/j.1600-065x.1991.tb00608.x. [DOI] [PubMed] [Google Scholar]
  26. Tepper R. I., Levinson D. A., Stanger B. Z., Campos-Torres J., Abbas A. K., Leder P. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell. 1990 Aug 10;62(3):457–467. doi: 10.1016/0092-8674(90)90011-3. [DOI] [PubMed] [Google Scholar]
  27. Vallé A., Zuber C. E., Defrance T., Djossou O., De Rie M., Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol. 1989 Aug;19(8):1463–1467. doi: 10.1002/eji.1830190818. [DOI] [PubMed] [Google Scholar]
  28. Vassiliadis S., Kyrpides N., Papamatheakis J. The role of IL-4 in human myeloid leukemia: stimulation of RNA synthesis and transduction of differentiation signals through an IL-4 receptor leads to functional and HLA positive HL-60 cells. Leuk Lymphoma. 1992 Jun;7(3):235–242. doi: 10.3109/10428199209053628. [DOI] [PubMed] [Google Scholar]
  29. Wertheim W. A., Kunkel S. L., Standiford T. J., Burdick M. D., Becker F. S., Wilke C. A., Gilbert A. R., Strieter R. M. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J Immunol. 1993 Aug 15;151(4):2166–2175. [PubMed] [Google Scholar]
  30. Wirth J. J., Kierszenbaum F., Zlotnik A. Effects of IL-4 on macrophage functions: increased uptake and killing of a protozoan parasite (Trypanosoma cruzi). Immunology. 1989 Feb;66(2):296–301. [PMC free article] [PubMed] [Google Scholar]
  31. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]
  32. Yamashita U., Tanaka Y., Shirakawa F. Suppressive effect of interleukin-4 on the differentiation of M1 and HL60 myeloid leukemic cells. J Leukoc Biol. 1993 Aug;54(2):133–137. doi: 10.1002/jlb.54.2.133. [DOI] [PubMed] [Google Scholar]
  33. Yen A., Brown D., Fishbaugh J. Precommitment states induced during HL-60 myeloid differentiation: possible similarities of retinoic acid- and DMSO-induced early events. Exp Cell Res. 1987 Nov;173(1):80–84. doi: 10.1016/0014-4827(87)90333-8. [DOI] [PubMed] [Google Scholar]
  34. te Velde A. A., Klomp J. P., Yard B. A., de Vries J. E., Figdor C. G. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol. 1988 Mar 1;140(5):1548–1554. [PubMed] [Google Scholar]
  35. van Leeuwen B. H., Martinson M. E., Webb G. C., Young I. G. Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood. 1989 Apr;73(5):1142–1148. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES